About Mytos
Mytos is a company based in London (United Kingdom) founded in 2016 by Ignacio Willats and Ali Afshar.. Mytos has raised $19 million across 1 funding round from investors including Buckley Ventures, IQ Capital and Wing Venture Capital. The company has 19 employees as of December 31, 2021. Mytos offers products and services including iDEM. Mytos operates in a competitive market with competitors including MaxCyte, SQZBiotech, Gemini Bio, Fluxion Biosciences and Berkeley Lights, among others.
- Headquarter London, United Kingdom
- Employees 19 as on 31 Dec, 2021
- Founders Ignacio Willats, Ali Afshar
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Mytos Bio Limited
- Date of Incorporation 19 Jan, 2016
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$19 M (USD)
in 1 rounds
-
Latest Funding Round
$19 M (USD), Series A
Nov 30, 2023
-
Investors
Buckley Ventures
& 2 more
-
Employee Count
19
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Mytos
Mytos offers a comprehensive portfolio of products and services, including iDEM. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Fully automates production of human cell types for regenerative medicine.
Unlock access to complete
Funding Insights of Mytos
Mytos has successfully raised a total of $19M through 1 strategic funding round. The most recent funding activity was a Series A round of $19 million completed in November 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $19.0M
-
First Round
First Round
(30 Nov 2023)
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2023 | Amount | Series A - Mytos | Valuation | Buckley Ventures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Mytos
Mytos has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Buckley Ventures, IQ Capital and Wing Venture Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are managed by a single-family office.
|
Founded Year | Domain | Location | |
|
Deep tech venture capital firm investing in European and global startups.
|
Founded Year | Domain | Location | |
|
Venture capital fund and fund of funds focused on early-stage startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Mytos
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Mytos
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Mytos Comparisons
Competitors of Mytos
Mytos operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as MaxCyte, SQZBiotech, Gemini Bio, Fluxion Biosciences and Berkeley Lights, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Instrument systems for cell processing and modification are provided.
|
|
| domain | founded_year | HQ Location |
Cell therapies are developed using proprietary Cell Squeeze technology.
|
|
| domain | founded_year | HQ Location |
Supplement reagents for cell and gene therapy are manufactured.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based tools for cellular analysis are provided.
|
|
| domain | founded_year | HQ Location |
Microfluidics-based systems for single-cell isolation and analysis are developed.
|
|
| domain | founded_year | HQ Location |
Developer of AI-based automated solutions for the preparation and analysis of microbiology culture specimens
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Mytos
Frequently Asked Questions about Mytos
When was Mytos founded?
Mytos was founded in 2016 and raised its 1st funding round 7 years after it was founded.
Where is Mytos located?
Mytos is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Mytos?
Ali Afshar is the current CEO of Mytos. They have also founded this company.
Is Mytos a funded company?
Mytos is a funded company, having raised a total of $19M across 1 funding round to date. The company's 1st funding round was a Series A of $19M, raised on Nov 30, 2023.
How many employees does Mytos have?
As of Dec 31, 2021, the latest employee count at Mytos is 19.
What does Mytos do?
The company was founded in 2016 and is based in London, United Kingdom. Operations focus on the biotechnology sector, where automated machine technology is utilized to create a cell manufacturing platform. Mammalian cells are grown through automated processes to support pharmaceutical and biotech businesses. Instruments for cell culture automation are provided as core offerings.
Who are the top competitors of Mytos?
Mytos's top competitors include MaxCyte, SQZBiotech and Thrive Bioscience.
What products or services does Mytos offer?
Mytos offers iDEM.
Who are Mytos's investors?
Mytos has 3 investors. Key investors include Buckley Ventures, IQ Capital, and Wing Venture Capital.